C12Q 2549/00
Reactions characterised by the features used to influence the efficiency or specificity
C12Q2549/00 (Reactions characterised by the features used to influence the efficiency or specificity) appears on 33 US grants and 48 published applications in this corpus.
Search patents in C12Q- Granted patents
- 33
- Published applications
- 48
- Assignees
- 32
- Inventors
- 95
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 2 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 2 | 2 |
| 2014 | 0 | 3 |
| 2015 | 2 | 2 |
| 2016 | 3 | 0 |
| 2017 | 2 | 3 |
| 2018 | 1 | 5 |
| 2019 | 0 | 4 |
| 2020 | 5 | 4 |
| 2021 | 3 | 5 |
| 2022 | 1 | 2 |
| 2023 | 4 | 2 |
| 2024 | 1 | 3 |
| 2025 | 2 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions relating to detection of recombination and rearrangement events9 Jun 2026US 12,651,645 B2Children's Medical Center Corporation
- Thermally responsive conjugates for DNA polymerase inhibition30 Sep 2025US 12,428,677 B2Tozaro Limited
- Detection of sequences uniquely associated with a DNA target region9 Sep 2025US 12,410,470 B2Pioneer Hi-Bred International, Inc.
- Method for measuring mutation rate16 Apr 2024US 11,959,131 B2Korea Institute of Oriental Medicine
- Methods of nucleic acid sample preparation24 Oct 2023US 11,795,492 B2ArcherDX, Inc.
- Circulating mutant dna to assess tumor dynamics9 Oct 2025US 2025/0313901 A1The Johns Hopkins University
- Method for obtaining immunoglobulin encoding nucleic acid1 May 2025US 2025/0137028 A1Hoffmann-La Roche Inc.
- Detection of sequences uniquely associated with a dna target region21 Mar 2024US 2024/0093315 A1Pioneer Hi-Bred International, Inc.
- Methods for determining a nucleotide sequence contiguous to a known target nucleotide sequence7 Mar 2024US 2024/0076727 A1The General Hospital Corporation
- Circulating mutant dna to assess tumor dynamics4 Jan 2024US 2024/0002948 A1The Johns Hopkins University
Most cited
By later US patents
- Methods for determining a nucleotide sequence contiguous to a known target nucleotide sequence83US 10,017,810 B2The General Hospital Corporation · 2018
- Detection of premalignant melanocytes12US 6,465,180 B1The Regents of the University of California · 2002
- Lipophilic quenching of viral inactivating agents9US 6,150,109 AV. I. Technologies, Inc. · 2000
- Linked linear amplification of nucleic acids9US 6,335,184 B12002
- Methods for determining a nucleotide sequence contiguous to a known target nucleotide sequence9US 9,487,828 B2The General Hospital Corporation · 2016